Cathie Wood Beam Therapeutics Inc. Transaction History
Ark Investment Management LLC
- $14 Billion
- Q1 2024
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 8,182,174 shares of BEAM stock, worth $201 Million. This represents 1.93% of its overall portfolio holdings.
Number of Shares
8,182,174
Previous 9,393,889
12.9%
Holding current value
$201 Million
Previous $256 Million
5.72%
% of portfolio
1.93%
Previous 1.53%
Shares
14 transactions
Others Institutions Holding BEAM
# of Institutions
240Shares Held
65.6MCall Options Held
311KPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA7.58MShares$187 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.71MShares$165 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.51MShares$111 Million0.69% of portfolio
-
Morgan Stanley New York, NY4.12MShares$102 Million0.01% of portfolio
-
State Street Corp Boston, MA3.73MShares$91.9 Million0.01% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.73B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...